Approvals/CIMA-AEMPS/ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)

Approved

STANDARD

ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 7a710a50bcc8f781
Drug Cima Aemps Name: ANORO ELLIPTA 55 MCG/22 MCG POLVO PARA INHALACION (UNIDOSIS)
Register Number: 114898002IP2
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Abacus Medicine A/S
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2025-04-10
Dosage Form: POLVO PARA INHALACIÓN (UNIDOSIS)
Dose: 55 MICROGRAMOS/22 MICROGRAMOS
Route Of Administration: VÍA INHALATORIA
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

UMECLIDINIO BROMURO

74,2 µg

VILANTEROL TRIFENATATO

40 µg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 10, 2025

Approval ID

7a710a50bcc8f781

Type

Standard